Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
BlackRock® Canada Announces Voting Results from Special Meeting of the iShares Premium Money Market ETF
-
Nauticus Robotics Announces Movement of Second Aquanaut Vehicle into the Acceptance Testing Phase
-
GeoPark Successfully Completes a $550 Million Notes Offering and Refinances More Than 80% of its Outstanding Notes Due 2027
-
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marqeta
-
NASA Presses Forward Search for VIPER Moon Rover Partner
-
Competitive Intelligence in Breast Cancer: Tracking the Evolving HR+ HER2-ve Breast Cancer Landscape
-
SK Telecom Joins MIT GenAI Impact Consortium
-
Cypher Updates Disclosure at the Request of the BCSC and CSE
-
Amir Shmueli Joins Ropes & Gray's Market-Leading Finance Practice in New York
-
Ibex Biosciences Launches Regulation D Campaign on Fundable
-
dLocal to Report Fourth Quarter 2024 Financial Results
-
ROSEN, A LEADING LAW FIRM, Encourages Sun Communities, Inc. Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - SUI
-
Jason Fair Named Managing Partner of Robins Kaplan California Offices
-
Chesapeake Utilities to Host its Fourth Quarter and Full-Year 2024 Earnings Conference Call and Webcast on February 27, 2025
-
BlackFort: Bridging the Gap to a Decentralized Future
-
Guggenheim Investments Announces February 2025 Closed-End Fund Distributions
-
Cynthia Gardens Introduces New Student Housing Options for FAU in Boca Raton, Florida
-
JEGI CLARITY Has Advised Strategus on Their Sale to CIVC Partners
-
PHOENIX INVESTORS ACQUIRES TWO INDUSTRIAL PROPERTIES FROM STELLANTIS
-
Community Health Center Data Breach Impacts Over 1 Million Individuals - Kehoe Law Firm, P.C. Investigating
-
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
-
Claros Mortgage Trust, Inc. Announces Tax Treatment of 2024 Dividends
-
Haviland Enviro Corp. Announces Resignation of CEO, CFO and Director
-
Cardinal Health Board of Directors Approves Quarterly Dividend
-
CASTLE & KEY DISTILLERY EXPANDS SUSTAINABILITY EFFORTS WITH MAJOR SOLAR ENERGY INVESTMENT
-
Marquis Who's Who Honors Thomas Francis Hospod IV for Expertise in Law and Real Estate
-
TMX Group Limited Reports Results for Fourth Quarter of 2024
-
TMX Group Limited Increases Dividend by 5% to $0.20 per Common Share
-
Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 3 February 2025
-
NEXUS CAPITAL MANAGEMENT ANNOUNCES ACQUISITION OF TRICAM INDUSTRIES
-
Altadena Residents File Lawsuit Against Southern California Edison Over Devastating Eaton Fire
-
Arctic Wolf and BlackBerry Announce Closing of Acquisition for Cylance
-
Pershing Square Holdings, Ltd. Releases Monthly Net Asset Value and Performance Report for January 2025
-
Wavelo Secures Four-Year Contract Renewal with EchoStar
-
Douglas Dynamics Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
Petrus Resources Declares Monthly Dividend for February 2025
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Electronic Arts Inc. Investors to Inquire About Securities Class Action Investigation - EA
-
TKO Miller Advises Midwest Stairs & Iron, Inc. on its Sale to R&B Wagner, Inc.
-
Roush Joins the Engine Technology Forum
-
A Diamond is Forever presents 67th annual Grammy Awards Jewelry Trend Report
-
Build-A-Bear Expands Popular 'After Dark' Valentine's Day Collection with Cuddly Cougar Gift Sets
-
NewMarket Corporation Reports Fourth Quarter and Full Year 2024 Results
-
Notice of Withdrawal and Refiling of Premerger Notification and Report Form Under the HSR Act
-
Tethys Petroleum Corporate Update
-
Prospect Capital Schedules Second Fiscal Quarter Earnings Release and Conference Call
-
NorthWest Copper Engages Media Services Consultant
-
Improved Pharma Announces New Scanning Electron Microscopy (SEM) Capabilities in Collaboration with Chemical Microscopy, LLC.
-
CEO Writes New Book Encouraging Business Leaders to Follow the Heart of God Revealed in the Psalms of King David
-
Revive Therapeutics Announces Update on R&D Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
-
Praxis Precision Medicines to Present at Two February Investor Conferences

